#ESMO22 Highlights on ADT duration with post-operative radiotherapy in prostate cancer: RADICALS-HD Published 2022-09-13 Download video MP4 360p Recommendations 03:30 ESMO Course in medical oncology for medical students: why should you apply? 01:52 Side Effects of Oxaliplatin 57:38 ESMO Patient Guides: Let's talk about oesophageal and stomach cancers 04:57 Precision Medicine in Carcinoma of Unknown Primary with Alwin Krämer 08:44 THIS guy solved Panic Attacks after 30 years of Panic Disorder 22:49 Highlights of the 2023 San Antonio Breast Cancer Symposium With Jason Mouabbi, MD 07:56 WHO-ESMO Collaboration Plan 2024-2026 02:56 #ESMO22 Highlights on cabozantinib with nivo and ipi for intermediate/poor risk adv. RCC: COSMIC-313 01:08 ESMO Sarcoma and Rare Cancers 2024: Why young oncologists should attend 01:52 ESMO Targeted Anticancer Therapies Congress 2024: Global Experts On Why You Should Secure Your Seat 01:19 ESMO Gastrointestinal Cancers Congress 2024: What To Expect 01:58 ESMO Sarcoma and Rare Cancers 2024: The Scientific Committee on why you should attend 01:35 ESMO Gastrointestinal Cancers Congress 2024: Why You Should Attend 01:48 #ELCC24: Reasons Why You Should Attend 01:46 #ESMOBreast24: Reasons to attend this top, international Congress for the breast cancer community 01:34 ESMO Sarcoma and Rare Cancers 2024: Reasons To Attend 03:39 Highlights from the ESMO Patient Guides event ‘Let's talk about oesophageal and stomach cancers’ 01:51 #ESMOBreast24: International breast cancer experts invite you to attend 01:59 ESMO Gastrointestinal Cancers Congress 2024: Reasons To Attend Similar videos 28:31 Prostate Cancer Highlights from ESMO 2022 01:19 Highlights in prostate cancer from ESMO 03:35 #ESMO22 Highlights on the efficacy and safety of fruquintinib in refractory mCRC: The FRESCO-2 study 02:30 #ESMO22 Highlights on first-line atezolizumab in NSCLC not eligible for platinum: The IPSOS study 02:05 STARTAR: ADT with apalutamide, radiation therapy and docetaxel in prostate cancer 16:33 Genitourinary Cancer ESMO 2022 Highlights - OncBrothers (Rohit & Rahul Gosain) w/ Dr. Toni Choueiri 01:17 When is ADT Used in Men Who Choose Prostatectomy? 06:41 ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022 01:27 Genitourinary cancer highlights at ESMO 2022 06:25 Practice-changing data from ESMO 2021 in prostate cancer 02:58 #ESMO22 Highlights on sacituzumab govitecan in HR+/HER2- metastatic breast cancer: TROPiCS-02 00:52 Clinical trial updates in prostate cancer at ESMO 2022 11:48 Localized Prostate Cancer: Androgen Deprivation Therapy (ADT) - 2021 Prostate Cancer Conference 08:59 Role of ADT with Radiation 03:41 SWOG S1216: ADT and TAK700 in prostate cancer 09:48 PCa Commentary September 2022: ADT & Radiotherapy 00:47 Systemic triple therapy in metastatic hormone-sensitive prostate cancer 1:00:27 Webinar: Predicting Benefit of ADT with RT in Prostate Cancer More results